ÓSKARE CAPITAL STRENGTHENS TEAM AND EXTENDS COVERAGE TO THE AMERICAS BY WELCOMING JD WECHSLER AS VENTURE PARTNER
As we prepare for our first closing in Q1 2021, Óskare Capital is pleased to announce that JD Wechsler will…
Read moreAs we prepare for our first closing in Q1 2021, Óskare Capital is pleased to announce that JD Wechsler will…
Read moreÓskare Capital is pleased to announce that Oliver Lamb will be joining as Co-Founder and Investment Manager in the investment…
Read moreMercia Asset Management has lost its investment director and university lead Nicola Broughton to a new $171m fund targeting the…
Read moreTHE Central Bank of Ireland has given the green light for an Irish domiciled investment fund that is seeking to…
Read moreIreland's first ever private equity medical cannabis fund has been established. The new venture has been set up by Crossroads…
Read moreOskare Capital lance Oskare Fund I, un fonds d'investissement qui va cibler des sociétés européennes développant des thérapies à base…
Read moreOctarine Bio IVS (“Octarine” or the “Company”), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial…
Read moreThe good news for Europe’s Medical Cannabis industry is that, although not specifically named, the sector has touch points in…
Read more